ClinicalTrials.Veeva

Menu

Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics (ECOTESTGER)

C

Centre Hospitalier de Lens

Status

Enrolling

Conditions

Memory Disorders
Neurocognitive Disorders

Treatments

Diagnostic Test: ecological MAI test

Study type

Interventional

Funder types

Other

Identifiers

NCT05668598
2022-A02139-34 (Other Identifier)
2022-02

Details and patient eligibility

About

In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.

Study test is ecological MAI. This test are assigned in two groups (with or without neurocognitive disorders).

Full description

In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.

Study test is ecological MAI. Participation will be 30 minutes for patients see in case of routine care and 2h30 for those accompanying the patients and participants recruited in external institutions.

Participants are assigned in two groups. Group 1 : with neurocognitive disorders Group 2 : without neurocognitive disorders

Benefits :

For participants without neurodegenerative disorder, study enables to take control early if anomaly will be detected.

The study permit to have cognitive assessment.

Risk : It's possible that participants feel tired. No constraints for participants seen during scheduled consultation.

Enrollment

60 estimated patients

Sex

All

Ages

70+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female ≥ 70 ans
  • Person have good locomotion, move independently
  • Personne agree to participate

Groupe 1 : 17≤MMSE≤24 (GRECO) Diagnosis of neurodegenerative diseases (major neurocognitive disorders: Alzheimer, mixed dementia, lobar frontotemporal degeneration, vascular dementia).

Groupe 2 : MMSE ≥ à 25 (GRECO) Without neurodegenerative disease

Exclusion criteria

  • Person with legal protective measures
  • Person deprived of liberty
  • Mental retardation or MMSE≤ 16
  • Understanding verbal disorders
  • Visual major disturbances
  • Person with disease causing increased fatigue
  • Person with psychiatric pathology excepted anxiety disorder or depression with mild episodes.
  • Person not covered by French national health insurance

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Groupe 1 : with neurocognitive disorders
Other group
Description:
with neurocognitive disorders
Treatment:
Diagnostic Test: ecological MAI test
Groupe 2 : without neurocognitive disorders
Other group
Description:
without neurocognitive disorders
Treatment:
Diagnostic Test: ecological MAI test

Trial contacts and locations

1

Loading...

Central trial contact

Brunhilde CANESSON; Mélanie VERLAY

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems